HealthQuill Articles by: HealthQuill
Novo Nordisk plans to invest 42 million Danish kroner ($6 billion) in Denmark to create new capacities for making active pharmaceutical ingredients and expand its portfolio within serious chronic diseases.
Drugs Health Pharma

Novo Nordisk plans $6 billion investment to expand in Denmark

HQ Team November 10, 2023: Novo Nordisk plans to invest 42 million Danish kroner ($6 billion) in Denmark to create new capacities for

Read More
A drug taken intravenously or inhaled proved to be more addictive as it enters the human brain more quickly than when taken orally, according to an agency of the US Department of Health and Human Services.
Drugs Health Pharma

Injecting drugs or inhaling them may up chances of addiction: NIH

HQ Team November 10, 2023: A drug taken intravenously or inhaled proved to be more addictive as it enters the human brain more

Read More
Valneva SE, a French vaccine maker, has got USFDA approval for its chikungunya vaccine, Ixchiq, to treat individuals older than 18 years of age and who are at increased risk of exposure to the disease.
Drugs Health Pharma

Valneva’s chikungunya jab gets FDA nod, first such for disease

HQ Team November 10, 2023: Valneva SE, a French vaccine maker, has got USFDA approval for its chikungunya vaccine, Ixchiq, to treat individuals

Read More
Eli Lilly’s weight-loss injection Zepbound, taken along as a supplement with diet and exercise, got the USFDA and UK regulator’s nod after clinical trials proved adults lost 48 pounds on average during treatment.
Drugs Health Pharma

US, UK regulators give green light to Eli Lilly’s weight-loss treatment

HQ Team November 9, 2023: Eli Lilly’s weight-loss injection Zepbound, to be taken along as a supplement with diet and exercise, got the

Read More
Chimpanzees spy on rival groups and confront them when there is a reduced risk, a study finds.
Drugs Health Pharma

Chimpanzees use high-ground reconnaissance to track rival groups 

Chimpanzees spy on rival groups and confront them when there is a reduced risk, a study finds.

Read More
More than 3,700 babies in the US were born with syphilis in 2022 — ten times the number in 2012 — and people from racial and ethnic minorities bore the brunt of the epidemic eight times more than White mothers.
Drugs Health Medical

Newborn syphilis cases rise ten-fold in 2022 in a decade in US: CDC data

More than 3,700 babies in the US were born with syphilis in 2022 — ten times the number in 2012 — and people

Read More
Last year about 7.5 million people had tuberculosis (TB), the world’s second-most infectious killer, and multi-drug resistant form of the disease remains a health crisis, the WHO stated.
Drugs Health Pharma

Globally, 7.5 million people got tuberculosis last year: WHO report

Last year about 7.5 million people had tuberculosis (TB), the world’s second-most infectious killer, and multi-drug resistant form of the disease remains a

Read More
Otsuka Medical Devices Co., announced its treatment for hypertension has got approval from the US Food and Drug Administration.
Health Medical Pharma

Otsuka Medical gets USFDA nod for treatment of hypertension  

Otsuka Medical Devices Co., announced its treatment for hypertension has got approval from the US Food and Drug Administration.

Read More
Johnson & Johnson will apply with the USFDA to start clinical trials in the second half of 2024 for its robotic surgical system.
Health Medical Pharma

J&J to file USFDA request to start trials for surgical robots

Johnson & Johnson will apply with the USFDA to start clinical trials in the second half of 2024 for its robotic surgical system.

Read More
Shareholders of Abcam Plc., a UK-based manufacturer and supplier of antibodies and reagents used for medical research, have approved a plan from US’s Danaher Corp to acquire the company for $5.7 billion.
Drugs Health Pharma

Abcam shareholders approve Danaher Corp acquisition for $5.7 billion

HQ Team November 7, 2023: Shareholders of Abcam Plc., a UK-based manufacturer and supplier of antibodies and reagents used for medical research, have

Read More